Edition:
India

Cerus Corp (CERS.OQ)

CERS.OQ on NASDAQ Stock Exchange Global Market

6.33USD
18 Sep 2020
Change (% chg)

$0.00 (+0.00%)
Prev Close
$6.33
Open
$6.40
Day's High
$6.42
Day's Low
$6.25
Volume
1,195,562
Avg. Vol
618,055
52-wk High
$7.90
52-wk Low
$2.71

Latest Key Developments (Source: Significant Developments)

Cerus Says Entered Into Credit Agreement
Tuesday, 2 Apr 2019 

April 1 (Reuters) - Cerus Corp ::CERUS CORP SAYS ON MARCH 29, CO ENTERED INTO A CREDIT, SECURITY AND GUARANTY AGREEMENT - SEC FILING.CERUS CORP - TERM LOAN CREDIT AGREEMENT PROVIDES A SECURED TERM LOAN FACILITY IN AN AGGREGATE PRINCIPAL AMOUNT OF UP TO $70.0 MILLION.  Full Article

Cerus Expects Full Year 2018 Product Revenue To Be $60.9 Million
Monday, 7 Jan 2019 

Jan 7 (Reuters) - Cerus Corp ::CERUS ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL YEAR 2018 PRODUCT REVENUE.2019 PRODUCT REVENUE GUIDANCE OF $70 MILLION TO $73 MILLION.UNAUDITED PRELIMINARY PRODUCT REVENUE FOR Q4 OF 2018 TOTALED $16.5 MILLION.EXPECTS FULL YEAR 2018 PRODUCT REVENUE TO BE $60.9 MILLION.Q4 REVENUE VIEW $19.9 MILLION -- REFINITIV IBES DATA.FY2018 REVENUE VIEW $74.2 MILLION -- REFINITIV IBES DATA.  Full Article

Cerus Q3 Loss Per Share $0.11
Friday, 2 Nov 2018 

Nov 1 (Reuters) - Cerus Corp ::ORATION REPORTS THIRD QUARTER 2018 RESULTS.Q3 LOSS PER SHARE $0.11.Q3 EARNINGS PER SHARE VIEW $-0.10 -- THOMSON REUTERS I/B/E/S.2018 PRODUCT REVENUE GUIDANCE REVISED UPWARDS TO A RANGE OF $58 MILLION TO $60 MILLION.PRODUCT REVENUE DURING Q3 OF 2018 WAS $15.4 MILLION, COMPARED TO $10.8 MILLION DURING SAME PERIOD IN 2017.Q3 REVENUE VIEW $20.0 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

BRIEF-Cerus Corp Reports Successful Inactivation Of Sars-Cov-2 With The Intercept Blood System For Plasma

* CERUS CORPORATION REPORTS SUCCESSFUL INACTIVATION OF SARS-COV-2 WITH THE INTERCEPT BLOOD SYSTEM FOR PLASMA